A carregar...
Voxelotor: A Ray of Hope for Sickle Disease
Sickle cell disease is one challenging blood disorder, affecting around 100,000 people in the United States alone. None of the currently approved drugs can modify the underlying pathology of the disease. Voxelotor, first of its kind, is an orally administered drug that can alter the underlying disea...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100618/ https://ncbi.nlm.nih.gov/pubmed/32257653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.7105 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|